ProMIS Neurosciences Inc. (PMN)
Data as of , from SEC Form 4 filings.
Net insider buying (90d)Watch PMN
See up to 3 months of PMN. The 7-day demo opens the 1M and 3M ranges and puts PMN on your watchlist.
Start 7-day demoLatest PMN insider trades
About ProMIS Neurosciences Inc. (PMN)
The SEC lists ProMIS Neurosciences Inc. under CIK 0001374339, in pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
PMN Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 1 | 2,280 | $30K |
| Grant or award | 1 | 80,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
PMN insider transactions (Form 4)
5545 Form 4 filings on record, the earliest from Oct 7, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Ivana Rubino - Officer | Grant or award | Option (right to buy) | 80,000 | $0.00 | - | |
| Johanne Kaplan - Officer | Open-market purchase | Common Shares | 2,280 | $13.30 | $30K | |
| William W. Wyman - Director | Grant or award | Option (right to buy) | 5,500 | $0.00 | - | |
| William W. Wyman - Director | Grant or award | Option (right to buy) | 11,000 | $0.00 | - | |
| Eugene Williams - Director | Grant or award | Option (right to buy) | 5,500 | $0.00 | - | |
| Eugene Williams - Director | Grant or award | Option (right to buy) | 11,000 | $0.00 | - | |
| Neil K. Warma - Officer | Grant or award | Option (right to buy) | 160,000 | $0.00 | - | |
| Madge K. Shafmaster - Director | Grant or award | Option (right to buy) | 5,500 | $0.00 | - | |
| Madge K. Shafmaster - Director | Grant or award | Option (right to buy) | 11,000 | $0.00 | - | |
| Neil Cashman - Officer | Grant or award | Option (right to buy) | 50,000 | $0.00 | - | |
| Max A. Milbury - Officer | Grant or award | Option (right to buy) | 18,167 | $0.00 | - | |
| Josh Mandel-Brehm - Director | Grant or award | Option (right to buy) | 5,500 | $0.00 | - | |
| Josh Mandel-Brehm - Director | Grant or award | Option (right to buy) | 11,000 | $0.00 | - | |
| Johanne Kaplan - Officer | Grant or award | Option (right to buy) | 50,000 | $0.00 | - | |
| Slanix Paul Alex - Director | Grant or award | Option (right to buy) | 5,500 | $0.00 | - | |
| Slanix Paul Alex - Director | Grant or award | Option (right to buy) | 11,000 | $0.00 | - | |
| Patrick D. Kirwin - Director | Open-market purchase | Common Shares | 4,000 | $11.33 | $45K | |
| Eugene Williams - Director | Open-market purchase | Common Shares | 2,000 | $24.40 | $49K | |
| Eugene Williams - Director | Open-market purchase | Common Shares | 1,000 | $22.53 | $23K | |
| Eugene Williams - Director | Open-market purchase | Common Shares | 1,000 | $21.89 | $22K | |
| Eugene Williams - Director | Open-market purchase | Common Shares | 2,000 | $24.00 | $48K | |
| Johanne Kaplan - Officer | Open-market purchase | Common Shares | 1,629 | $15.35 | $25K | |
| Neil Cashman - Officer | Grant or award | Common Shares | 4,122 | $12.13 footnote F1 | $50K | |
| Neil Cashman - Officer | Grant or award | Warrants to purchase Common Shares | 4,122 | - footnote F1 | - | |
| ||||||
| Johanne Kaplan - Officer | Grant or award | Common Shares | 2,060 | $12.13 footnote F1 | $25K | |
| Johanne Kaplan - Officer | Grant or award | Warrants to purchase Common Shares | 2,060 | - footnote F1 | - | |
| ||||||
| Neil K. Warma - Officer | Grant or award | Common Shares | 6,183 | $12.13 footnote F1 | $75K | |
| Neil K. Warma - Officer | Grant or award | Warrants to purchase Common Shares | 6,183 | - footnote F1 | - | |
| ||||||
| Max A. Milbury | Grant or award | Common Shares | 6,595 | $12.13 footnote F1 | $80K | |
| Max A. Milbury | Grant or award | Warrants to purchase Common Shares | 6,595 | - footnote F1 | - | |
| ||||||
| Patrick D. Kirwin - Director | Grant or award | Common Shares | 3,050 | $12.13 footnote F1 | $37K | |
| Patrick D. Kirwin - Director | Grant or award | Warrants to purchase Common Shares | 3,050 | - footnote F1 | - | |
| ||||||
| ABG Management Ltd. - 10% Owner | Open-market purchase | Common Shares | 700,741 | $12.13 footnote F1 | $8.50M | |
| ABG Management Ltd. - 10% Owner | Open-market purchase | Warrants | 700,741 | - footnote F1 | - | |
| ||||||
| ABG Management Ltd. - 10% Owner | Grant or award | Option (right to buy) | 40,000 | $0.00 | - | |
| Max A. Milbury | Open-market purchase | Common Shares | 30,392 | $0.49 | $15K | |
| Jeremy M. Sclar 2012 Irrevocable Family Trust - 10% Owner | Other | Common Shares, no par value | 697,674 | - | - | |
| Jeremy M. Sclar 2012 Irrevocable Family Trust - 10% Owner | Other | Common Shares, no par value | 697,674 | - | - | |
| Jeremy M. Sclar 2012 Irrevocable Family Trust - 10% Owner | Other | Common Shares, no par value | 697,674 | - | - | |
| Jeremy M. Sclar 2012 Irrevocable Family Trust - 10% Owner | Other | Tranche A Common Share Purchase Warrants | 697,674 | $0.00 | - | |
| Jeremy M. Sclar 2012 Irrevocable Family Trust - 10% Owner | Other | Tranche B Common Share Purchase Warrants | 697,674 | $0.00 | - | |
| Jeremy M. Sclar 2012 Irrevocable Family Trust - 10% Owner | Other | Tranche C Common Share Purchase Warrants | 697,674 | $0.00 | - | |
| Jeremy M. Sclar 2012 Irrevocable Family Trust - 10% Owner | Open-market purchase | Warrant to Purchase Common Shares | 3,139,533 | - | - | |
| Johanne Kaplan - Officer | Grant or award | Option (right to buy) | 165,000 | $0.00 | - | |
| Neil Cashman - Officer | Grant or award | Option (right to buy) | 165,000 | $0.00 | - | |
| Max A. Milbury | Grant or award | Option (right to buy) | 60,000 | $0.00 | - | |
 Larry Douglas Altstiel - Officer | Grant or award | Option (right to buy) | 165,000 | $0.00 | - | |
| Neil K. Warma - Officer | Grant or award | Option (right to buy) | 600,000 | $0.00 | - | |
| Jeremy M. Sclar - 10% Owner | Other | Common Shares, no par value | 697,674 | - | - | |
| Jeremy M. Sclar - 10% Owner | Other | Common Shares, no par value | 697,674 | - | - | |
| Jeremy M. Sclar - 10% Owner | Other | Common Shares, no par value | 697,674 | - | - | |
| Jeremy M. Sclar - 10% Owner | Other | Tranche A Common Share Purchase Warrants | 697,674 | $0.00 | - | |
| Jeremy M. Sclar - 10% Owner | Other | Tranche B Common Share Purchase Warrants | 697,674 | $0.00 | - | |
| Jeremy M. Sclar - 10% Owner | Other | Tranche C Common Share Purchase Warrants | 697,674 | $0.00 | - | |
| Jeremy M. Sclar - 10% Owner | Open-market purchase | Warrant to Purchase Common Shares | 3,139,533 | - | - | |
Item 2.02, 9.01
Item 7.01, 8.01, 9.01
Item 5.02, 5.07, 9.01
Item 2.02, 9.01
PMN insider trading FAQ
What is the latest insider trade for PMN?
ProMIS Neurosciences Inc. (PMN) had 2 insider filings in the last 90 days, with the most recent on 2026-10-06. The full record for PMN runs to 45 Form 4 filings, the earliest from 2024-10-07. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying PMN stock?
1 insider purchase of PMN was filed in the last 90 days, totaling $30K.
How many insiders are selling PMN stock?
No insider sales of PMN were filed in the last 90 days. 1 sale is on record for this company.
Where can I see PMN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects PMN Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Ivana Rubino view on EDGAR
- - Johanne Kaplan view on EDGAR
- - William W. Wyman view on EDGAR
- - Eugene Williams view on EDGAR
- - Neil K. Warma view on EDGAR
- - Madge K. Shafmaster view on EDGAR
- - Neil Cashman view on EDGAR
- - Max A. Milbury view on EDGAR
- - Josh Mandel-Brehm view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Health Care
- Where PMN's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow PMN with a 7-day demo
- PMN on your watchlist
- Every PMN Form 4 filing on record
- Up to 3 months of PMN price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
